Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Subscriber?
Search

Volume XXXII, No. 15 - October 27, 2025

CAP Regains Veterans’ Affairs Lab Accreditation Contract

TDR Insider /

In a blow to The Joint Commission, the US Department of Veterans Affairs has awarded a new clinical laboratory accreditation contract to the College of American Pathologists (CAP). The decision highlights the competition between the two accrediting organizations and sheds light on how CAP’s inspection process holds value to the federal agency. The deal could […]

To access this post, you must purchase The Dark Report.

CAP Regains Veterans’ Affairs Lab Accreditation Contract Read More »

More Signs of Shifting Sands in the Lab World

Commentary and Opinion by R. Lewis Dark /

If you feel like the ground is shifting under your feet in the clinical laboratory world, I would agree with you. It’s clear that situations are changing in the diagnostics market. This issue of The Dark Report is stocked with evidence of our observation. Take, for example, the lead briefing, which digs into the College

To access this post, you must purchase The Dark Report.

More Signs of Shifting Sands in the Lab World Read More »

CAP Regains VA Lab Accreditation Contract

Laboratory Management /

CEO SUMMARY: In a blow to The Joint Commission, the US Department of Veterans Affairs has awarded a new clinical laboratory accreditation contract to the College of American Pathologists (CAP). The decision highlights the competition between the two accrediting organizations and sheds light on how CAP’s inspection process holds value to the federal agency. The

To access this post, you must purchase The Dark Report.

CAP Regains VA Lab Accreditation Contract Read More »

Pathology Journals Not Immune to Questionable Studies

Pathology Trends /

As we recently reported, scientific fraud is more prevalent than many people in the science community would like to admit. The “publish or perish” mindset in academia has led to a proliferation of questionable and even fabricated papers in peer-reviewed journals. But to what extent do these problems apply to pathology and laboratory medicine? Quite

To access this post, you must purchase The Dark Report.

Pathology Journals Not Immune to Questionable Studies Read More »

Accreditors Explain Changes to CLIA Supervisor Qualifications

Laboratory Compliance /

In December 2023, the Centers for Medicare and Medicaid Services (CMS) announced major updates to the Clinical Laboratory Improvement Amendments (CLIA) personnel regulations, which went into effect on December 28, 2024. During a panel discussion at the 2025 Executive War College on Diagnostics, Clinical Laboratory, and Pathology Management, four speakers from the major accrediting organizations

To access this post, you must purchase The Dark Report.

Accreditors Explain Changes to CLIA Supervisor Qualifications Read More »

Oracle Hopes to Sway Market with New AI-Assisted EHR

Clinical Laboratory Trends /

W hile it remains to be seen whether it truly pushes boundaries, Oracle Health got attention when recently announcing it had released an immersive, next-generation electronic health records (EHR) platform fueled by artificial intelligence (AI). The system is conversational, contextual, and can achieve complex tasks, according to the tech giant. Clinical laboratory observers will be

To access this post, you must purchase The Dark Report.

Oracle Hopes to Sway Market with New AI-Assisted EHR Read More »

FDA Has Future Avenues to LDT Oversight

In Vitro Diagnostics /

CEO SUMMARY: Even though a federal court vacated the FDA’s final rule for laboratory developed tests, experts warn that the agency may still be able to regulate some LDTs via its authority over diagnostic software. An attorney notes that software’s central role in modern lab tests could allow FDA oversight. Long-term regulatory clarity is needed

To access this post, you must purchase The Dark Report.

FDA Has Future Avenues to LDT Oversight Read More »

October 27, 2025, Intelligence: Late-Breaking Lab News

Late Breaking Lab News /

In yet another shuffling of the in vitro diagnostics (IVD) space, Hologic announced on Oct. 21 that it was being acquired by private equity firms Blackstone and TPG for $18.3 billion. The deal will take Hologic off the Nasdaq, likely in early 2026. TPG and Blackstone lauded Hologic’s focus on women’s health. Hologic earned approximately

To access this post, you must purchase The Dark Report.

October 27, 2025, Intelligence: Late-Breaking Lab News Read More »

Facebook-f Twitter Linkedin-in

The Dark Report
1000 N West Street, Suite 1200 Wilmington, Delaware, United States, 19801
Phone: 512-264-7103
Email: info@darkreport.com

© 2025 The Dark Report. All rights reserved. Part of the LabX Media Group

;